Page results
-
Preterm infants do not get used to repeated pain in the way that full-term infants, children and adults do habituate to pain, finds a study at UCLH and UCL.
-
Having proton beam therapy: information for teenagers aged 13-17 patient information
-
A major new consortium led by UCLH and UCL has been awarded £6.8 million by the National Institute of Health Research to conduct the largest clinical study of long COVID over the next two years.
-
Well done to everyone who ran to support UCLH in the iconic London Landmarks Half Marathon on 2 April!
-
The UCLH@Home service is helping patients like 80-year-old Margaret Stone to continue their recovery in their own home under the care of their hospital team.
-
A new research study at UCLH and UCL will investigate how a rare type of blood cancer develops and what types of treatment may be effective for patients.
-
A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.
-
UCLH research manager Sarah Taylor has won a national leadership award for her work to develop and train research staff.
-
UCLH consultant neurologist Dr Catherine Mummery has been announced as the new Chair of the NIHR Dementia Translational Research Collaboration.
-
Our vaccination centre at the Business Design Centre, Islington, closed on Monday 10 January.
File results
-
FOI/2023/0353 - Junior doctors remuneration for days on strike/will be on strike
-
FOI/2023/0352 - Data security training, data breach reporting, security budgets
-
FOI/2023/0345 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI201730 Cancelled cancer operations
-
FOI/2023/0344 - Number of neonatal and stillbirth deaths since January 2013
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0342 - Self-administration of medication policies
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology